In a human model of breast cancer survivors that performed exercise on cycle ergometers three times per week for 15 weeks, no differences in insulin, glucose or IGFBP-1 were observed, although IGF-1 was reduced and IGFBP-3 was elevated in the exercise group [175]. The gene discussed is IGF1; the disease is breast cancer.